ClinicalTrials.govpublic full text
Immunochemotherapy, in Vivo Purging, PBSC Mobilization and Autotransplant in Relapsed or Refractory Follicular Lymphoma
follicular lymphoma, rituximab, immunochemotherapy, peripheral blood stem cells (pbsc) mobilization, in vivo purging, autotransplant, bcl-2 rearrangement, molecular response, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 857664
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.